ID | Age | Sex | Treatment options | Patients’ Final decisions | Treatment to alleviate cancer symptoms | Previous cancer history |
1 | Early 80s | M | Clinical trials or standard treatment | Standard treatment (oral molecular targeting agents) | - | ? |
2 | Late 70s | M | Anti-cancer agents or palliative care alone | Anti-cancer agents (oral) | - | - |
3 | Late 80s | M | Whether to receive or not receive oral molecular targeting agents | Oral molecular targeting agents | ? | ? |
4 | Early 80s | F | Whether to receive or not receive oral molecular targeting agents | Oral molecular targeting agents | - | - |
5 | Late 70s | M | Anti-cancer agents or palliative care alone | Anti-cancer agents (iv) | ? | - |
6 | Late 70s | M | Clinical trials or standard treatment | Clinical trials (anti-cancer agents; iv and oral) | - | ? |
7 | Early 70s | M | Clinical trials or standard treatment | Clinical trials (anti-cancer agents; iv) | ? | - |
8 | Early 70s | M | Clinical trials or standard treatment | Clinical trials (anti-cancer agents; iv and oral) | ? | - |
9 | Early 70s | M | Clinical trials or standard treatment | Clinical trials (anti-cancer agents; iv) | ? | - |
10 | Early 80s | M | Whether to receive or not receive anti-cancer agents | Anti-cancer agents (iv) | - | - |
11 | Early 70s | F | Clinical trials or standard treatment | Standard treatment(anti-cancer agents; iv) | - | - |
12 | Late 70s | M | Anti-cancer agents or palliative care alone | Anti-cancer agents (iv) | - | - |
13 | Early 70s | M | Whether to receive or not receive anti-cancer agents | Anti-cancer agents (iv and oral) | - | - |
14 | Late 70s | F | Clinical trials or standard treatment | Clinical trials (anti-cancer agents; iv) | ? | - |
15 | Late 70s | M | Whether to receive or not receive anti-cancer agents | Anti-cancer agents (iv) | - | - |
16 | Late 70s | F | Whether to receive or not receive oral molecular targeting agents | Oral molecular targeting agents | ? | - |
17 | Late 70s | M | Whether to receive or not receive anti-cancer agents | Anti-cancer agents (iv) | ? | - |